Clinical Trial Update: Adrenal Function and Use of Intralesional Triamcinolone Acetonide 10 mg/mL (Kenalog-10) in Patients With Alopecia Areata [Phase 2]

View source ↗

Summary

Phase 2 study evaluating adrenal function in alopecia areata patients treated with intralesional Triamcinolone acetonide 10 mg/mL (Kenalog-10); results have bee…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia Areata

Drugs mentioned

• KENALOG-10 (Triamcinolone acetonide)

Snippet

Sponsor: University of Minnesota | Conditions: Alopecia Areata | Phase 2 | Status: COMPLETED | Results posted: 2014-06-20